These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Epigenetic and metabolic programming of innate immunity in sepsis. Vachharajani V; McCall CE Innate Immun; 2019 Jul; 25(5):267-279. PubMed ID: 30997862 [TBL] [Abstract][Full Text] [Related]
4. Transcriptomic Profiles in Children With Septic Shock With or Without Immunoparalysis. Snyder A; Jedreski K; Fitch J; Wijeratne S; Wetzel A; Hensley J; Flowers M; Bline K; Hall MW; Muszynski JA Front Immunol; 2021; 12():733834. PubMed ID: 34659221 [TBL] [Abstract][Full Text] [Related]
5. Imbalance of Circulating Innate Lymphoid Cell Subpopulations in Patients With Septic Shock. Carvelli J; Piperoglou C; Bourenne J; Farnarier C; Banzet N; Demerlé C; Gainnier M; Vély F Front Immunol; 2019; 10():2179. PubMed ID: 31616411 [No Abstract] [Full Text] [Related]
6. Epigenetics of Sepsis. Binnie A; Tsang JLY; Hu P; Carrasqueiro G; Castelo-Branco P; Dos Santos CC Crit Care Med; 2020 May; 48(5):745-756. PubMed ID: 32167492 [TBL] [Abstract][Full Text] [Related]
7. Sepsis, immunosuppression and the role of epigenetic mechanisms. Córneo EDS; Michels M; Dal-Pizzol F Expert Rev Clin Immunol; 2021 Feb; 17(2):169-176. PubMed ID: 33596148 [No Abstract] [Full Text] [Related]
8. Epigenetics in Sepsis: Understanding Its Role in Endothelial Dysfunction, Immunosuppression, and Potential Therapeutics. Cross D; Drury R; Hill J; Pollard AJ Front Immunol; 2019; 10():1363. PubMed ID: 31275313 [TBL] [Abstract][Full Text] [Related]
9. Identification of biomarkers of response to IFNg during endotoxin tolerance: application to septic shock. Allantaz-Frager F; Turrel-Davin F; Venet F; Monnin C; De Saint Jean A; Barbalat V; Cerrato E; Pachot A; Lepape A; Monneret G PLoS One; 2013; 8(7):e68218. PubMed ID: 23874546 [TBL] [Abstract][Full Text] [Related]
10. Alterations in leukocyte DNA methylome are associated to immunosuppression in severe clinical phenotypes of septic patients. Beltrán-García J; Casabó-Vallés G; Osca-Verdegal R; Navarrete-López P; Rodriguez-Gimillo M; Nacher-Sendra E; Ferrando-Sánchez C; García-López E; Pallardó FV; Carbonell N; Mena-Mollá S; García-Giménez JL Front Immunol; 2023; 14():1333705. PubMed ID: 38235139 [TBL] [Abstract][Full Text] [Related]
11. Epigenetic mechanisms of Immune remodeling in sepsis: targeting histone modification. Wu D; Shi Y; Zhang H; Miao C Cell Death Dis; 2023 Feb; 14(2):112. PubMed ID: 36774341 [TBL] [Abstract][Full Text] [Related]
12. Induction of innate immune memory via microRNA targeting of chromatin remodelling factors. Seeley JJ; Baker RG; Mohamed G; Bruns T; Hayden MS; Deshmukh SD; Freedberg DE; Ghosh S Nature; 2018 Jul; 559(7712):114-119. PubMed ID: 29950719 [TBL] [Abstract][Full Text] [Related]
13. Removal of increased circulating CD4+CD25+Foxp3+ regulatory T cells in patients with septic shock using hemoperfusion with polymyxin B-immobilized fibers. Ono S; Kimura A; Hiraki S; Takahata R; Tsujimoto H; Kinoshita M; Miyazaki H; Yamamoto J; Hase K; Saitoh D Surgery; 2013 Feb; 153(2):262-71. PubMed ID: 22884251 [TBL] [Abstract][Full Text] [Related]
14. HLA-A Locus is Associated With Sepsis and Septic Shock After Traumatic Injury. Horn DL; Mindrinos M; Anderson K; Krishnakumar S; Wang C; Li M; Hollenbach J; O'Keefe GE Ann Surg; 2022 Jan; 275(1):203-207. PubMed ID: 33064392 [TBL] [Abstract][Full Text] [Related]
15. Identification of CD177 as the most dysregulated parameter in a microarray study of purified neutrophils from septic shock patients. Demaret J; Venet F; Plassais J; Cazalis MA; Vallin H; Friggeri A; Lepape A; Rimmelé T; Textoris J; Monneret G Immunol Lett; 2016 Oct; 178():122-30. PubMed ID: 27568821 [TBL] [Abstract][Full Text] [Related]
16. The impact of age on the innate immune response and outcomes after severe sepsis/septic shock in trauma and surgical intensive care unit patients. Brakenridge SC; Efron PA; Stortz JA; Ozrazgat-Baslanti T; Ghita G; Wang Z; Bihorac A; Mohr AM; Brumback BA; Moldawer LL; Moore FA J Trauma Acute Care Surg; 2018 Aug; 85(2):247-255. PubMed ID: 29613958 [TBL] [Abstract][Full Text] [Related]
17. The use of immunocompromised animals as models for human septic shock. Opal SM; Cross AS Shock; 2005 Dec; 24 Suppl 1():64-70. PubMed ID: 16374375 [TBL] [Abstract][Full Text] [Related]
18. Regulation of Cellular Immune Responses in Sepsis by Histone Modifications. Carson WF; Kunkel SL Adv Protein Chem Struct Biol; 2017; 106():191-225. PubMed ID: 28057212 [TBL] [Abstract][Full Text] [Related]
19. The REAnimation Low Immune Status Markers (REALISM) project: a protocol for broad characterisation and follow-up of injury-induced immunosuppression in intensive care unit (ICU) critically ill patients. Rol ML; Venet F; Rimmele T; Moucadel V; Cortez P; Quemeneur L; Gardiner D; Griffiths A; Pachot A; Textoris J; Monneret G; BMJ Open; 2017 Jun; 7(6):e015734. PubMed ID: 28637738 [TBL] [Abstract][Full Text] [Related]
20. The immunopathogenesis of sepsis in elderly patients. Opal SM; Girard TD; Ely EW Clin Infect Dis; 2005 Nov; 41 Suppl 7():S504-12. PubMed ID: 16237654 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]